BEDMINSTER, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central ...
Intra-Cellular (ITCI) Therapies announced presentations about lumateperone including the results from Phase 3 adjunctive Major Depressive Disorder Studies 501 and 502 at Psych Congress held October 29 ...
The Neuroscience ACCUMIN panel is comprised of international experts associated with leading mental healthcare education brands Psych Congress and Neuroscience Education Institute (NEI). Membership in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results